Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Venous Thromboembolism Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)WithdrawnNCT03988231
What this trial is testing

Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study

Who this might be right for
Venous ThromboembolismBleeding as Surgical Complication (Treatment)Deep Venous Thrombosis+1 more
University of Utah
Not applicableStudy completedNCT01851239
What this trial is testing

Venous Thromboembolism Prophylaxis in Medical and Surgical ICUs in a Single University Hospital

Who this might be right for
Venous Thromboembolism
Yonsei University 1,000
Very early researchEnded earlyNCT02331095
What this trial is testing

Statin Use in Patients With Acute VTE

Who this might be right for
Venous Thromboembolism
Ohio State University 21
Post-approval studies (Phase 4)Ended earlyNCT00655122
What this trial is testing

Prophylaxis In Venous Thromboembolism In Primary Care, A Pilot Study

Who this might be right for
ThromboembolismDeep Vein ThrombosisDalteparin
Pfizer 8
Not applicableStudy completedNCT00005496
What this trial is testing

Inflammation, Infection, and Future Cardiovascular Risk

Who this might be right for
Cardiovascular DiseasesCoronary DiseaseCerebrovascular Accident+9 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableStudy completedNCT06445283
What this trial is testing

Determination of Venous Thromboembolism Risk and Nursing Practices in Patients Hospitalized in Medical Services

Who this might be right for
Venous Thromboembolism
Hacettepe University 157
Testing effectiveness (Phase 2)Ended earlyNCT02901067
What this trial is testing

STAT-STatin and Aspirin in Trauma

Who this might be right for
Wounds and InjuriesVenous Thromboembolism
Denver Health and Hospital Authority 43
Testing effectiveness (Phase 2)Study completedNCT01225822
What this trial is testing

BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 1,973
Not applicableUnknownNCT04663477
What this trial is testing

Development and Validation of the Patient-completed Caprini Risk Score

Who this might be right for
Venous Thromboembolism
China-Japan Friendship Hospital 1,017
Testing effectiveness (Phase 2)Ended earlyNCT04106700
What this trial is testing

Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs

Who this might be right for
Venous Thromboembolism
Instituto de Investigacion Sanitaria La Fe 60
Not applicableStudy completedNCT00138099
What this trial is testing

Dalteparin's Influence on Renally Compromised: Anti-Ten-A Study (DIRECT)

Who this might be right for
Renal Insufficiency
Hamilton Health Sciences Corporation 140
Large-scale testing (Phase 3)Study completedNCT01274637
What this trial is testing

PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot

Who this might be right for
Venous ThromboembolismPostpartum
Ottawa Hospital Research Institute 62
Large-scale testing (Phase 3)Study completedNCT04444700
What this trial is testing

A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic

Who this might be right for
COVIDCoronavirus InfectionSevere Acute Respiratory Syndrome+2 more
University of Sao Paulo General Hospital 465
Not applicableStudy completedNCT00745212
What this trial is testing

Evaluation of an Antithrombotic Therapeutic Strategy in Pregnant Women

Who this might be right for
Placental Vascular PathologiesVenous Thromboembolism Diseases
Centre Hospitalier Universitaire de Saint Etienne 2,280
Post-approval studies (Phase 4)Study completedNCT00264277
What this trial is testing

D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
IRCCS Azienda Ospedaliero-Universitaria di Bologna 600
Not applicableStudy completedNCT01598805
What this trial is testing

Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts

Who this might be right for
Venous Thromboembolism
University of Zurich 10,000
Testing effectiveness (Phase 2)Study completedNCT04243122
What this trial is testing

Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients

Who this might be right for
Myeloproliferative Neoplasm (MPN)Essential Thrombocythemia (ET)JAK2 Mutation+3 more
Ottawa Hospital Research Institute 44
Testing effectiveness (Phase 2)Study completedNCT02170701
What this trial is testing

BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgery

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 289
Large-scale testing (Phase 3)Looking for participantsNCT04924322
What this trial is testing

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

Who this might be right for
Deep Venous Thrombosis
Yale University 258
Large-scale testing (Phase 3)Ended earlyNCT05171049
What this trial is testing

A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolism
Anthos Therapeutics, Inc. 1,150
Next Page